Beyond Air Inc (XAIR) Stock Price, Quote & News

Company Profile

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiol...

Industry: Medical Devices

Sector: Healthcare

Phone: 516 665 8200

Website: www.beyondair.net

Address:

900 Stewart Avenue, Suite 301, Garden City, United States

MavisBeacon Aug. 5 at 8:06 PM

$XAIR and it closed at a NEW all time low

1 · Reply

MavisBeacon Aug. 5 at 7:02 PM

$XAIR .138 pre r/s One cent from the all time low. Great work, everyone.

0 · Reply

good7 Aug. 5 at 3:59 PM

$XAIR

1 · Reply

MavisBeacon Aug. 5 at 1:40 PM

$XAIR no bids, as usual. this stock is just dead. keeps falling to new lows on low volume but there's simply nobody buying the stock

0 · Reply

jlfromli Aug. 4 at 8:38 PM

$XAIR I’m a buyer At $.50 Maybe. 🤔

0 · Reply

MavisBeacon Aug. 4 at 8:12 PM

$XAIR what a great stock this is. the market is near all time highs and this turd closes at a new low every single day

1 · Reply

VernCapital Aug. 4 at 4:36 PM

$XAIR 14c 🤦🏻‍♂️

1 · Reply

VernCapital Aug. 4 at 4:35 PM

$XAIR This! keep testing support over and over …it will break

0 · Reply

MavisBeacon Aug. 4 at 3:48 PM

$XAIR i just passed Lisi in New York. He's not looking good

0 · Reply

MavisBeacon Aug. 4 at 11:26 AM

$XAIR $8 today. Anyone?

1 · Reply

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 22, 2025, 7:30 AM EDT - 15 days ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jun 17, 2025, 9:53 PM EDT - 7 weeks ago

Beyond Air, Inc. (XAIR) Q4 2025 Earnings Call Transcript

Jun 17, 2025, 4:32 PM EDT - 7 weeks ago

Beyond Air Stock Dips After Mixed Q4 Results: Here's What To Know

Jun 17, 2025, 4:01 PM EDT - 7 weeks ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 16, 2025, 8:00 AM EDT - 7 weeks ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Jun 16, 2025, 7:20 AM EDT - 7 weeks ago

Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings

May 20, 2025, 8:00 AM EDT - 2 months ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

Apr 21, 2025, 4:05 PM EDT - 3 months ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 15, 2025, 4:05 PM EDT - 4 months ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 9, 2025, 4:05 PM EDT - 4 months ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Mar 31, 2025, 8:00 AM EDT - 4 months ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 24, 2025, 4:05 PM EDT - 4 months ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 11, 2025, 7:30 AM EDT - 5 months ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Mar 6, 2025, 4:05 PM EST - 5 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Feb 10, 2025, 7:25 PM EST - 6 months ago

Beyond Air, Inc. (XAIR) Q3 2025 Earnings Call Transcript

Feb 10, 2025, 4:05 PM EST - 6 months ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 5, 2025, 9:29 AM EST - 6 months ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Jan 27, 2025, 4:05 PM EST - 6 months ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 24, 2025, 9:15 AM EST - 6 months ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Dec 9, 2024, 11:00 AM EST - 8 months ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 3, 2024, 4:05 PM EST - 8 months ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 2, 2024, 7:30 AM EST - 8 months ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Nov 26, 2024, 7:30 AM EST - 9 months ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 14, 2024, 4:05 PM EST - 9 months ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 11, 2024, 7:56 PM EST - 9 months ago

Beyond Air, Inc. (XAIR) Q2 2025 Earnings Call Transcript

Nov 11, 2024, 4:05 PM EST - 9 months ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Oct 29, 2024, 4:22 PM EDT - 10 months ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 7, 2024, 7:00 AM EDT - 10 months ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 2, 2024, 7:30 AM EDT - 11 months ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Sep 27, 2024, 7:34 AM EDT - 11 months ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:32 AM EDT - 11 months ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:30 AM EDT - 11 months ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Sep 23, 2024, 8:00 AM EDT - 11 months ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Jul 31, 2024, 4:15 PM EDT - 1 year ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Jul 23, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Jul 16, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Jun 24, 2024, 5:48 PM EDT - 1 year ago

Beyond Air, Inc. (XAIR) Q4 2024 Earnings Call Transcript

Jun 24, 2024, 4:15 PM EDT - 1 year ago

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Jun 24, 2024, 3:32 AM EDT - 1 year ago

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

EPAC OMIC ITI STOK

Jun 13, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® Appoints David Webster as Chief Commercial Officer

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

May 23, 2024, 4:09 PM EDT - 1 year ago

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

Mar 20, 2024, 9:00 AM EDT - 1 year ago

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Feb 13, 2024, 2:37 AM EST - 1 year ago

Beyond Air, Inc. (XAIR) Q3 2024 Earnings Call Transcript

Feb 12, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

Jan 18, 2024, 8:00 AM EST - 1 year ago

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

$Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors$

Dec 27, 2023, 7:30 AM EST - 1 year ago

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

Nov 15, 2023, 4:05 PM EST - 1 year ago

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

Nov 13, 2023, 7:07 PM EST - 1 year ago

Beyond Air, Inc. (XAIR) Q2 2024 Earnings Call Transcript

MavisBeacon Aug. 5 at 8:06 PM

$XAIR and it closed at a NEW all time low

1 · Reply

MavisBeacon Aug. 5 at 7:02 PM

$XAIR .138 pre r/s One cent from the all time low. Great work, everyone.

0 · Reply

good7 Aug. 5 at 3:59 PM

$XAIR

1 · Reply

MavisBeacon Aug. 5 at 1:40 PM

$XAIR no bids, as usual. this stock is just dead. keeps falling to new lows on low volume but there's simply nobody buying the stock

0 · Reply

jlfromli Aug. 4 at 8:38 PM

$XAIR I’m a buyer At $.50 Maybe. 🤔

0 · Reply

MavisBeacon Aug. 4 at 8:12 PM

$XAIR what a great stock this is. the market is near all time highs and this turd closes at a new low every single day

1 · Reply

VernCapital Aug. 4 at 4:36 PM

$XAIR 14c 🤦🏻‍♂️

1 · Reply

VernCapital Aug. 4 at 4:35 PM

$XAIR This! keep testing support over and over …it will break

0 · Reply

MavisBeacon Aug. 4 at 3:48 PM

$XAIR i just passed Lisi in New York. He's not looking good

0 · Reply

MavisBeacon Aug. 4 at 11:26 AM

$XAIR $8 today. Anyone?

1 · Reply

CumulativeChaser Aug. 4 at 10:15 AM

$PAPL $XAIR $PASG $NXTC ...

0 · Reply

MavisBeacon Aug. 1 at 7:25 PM

$XAIR Knowing Lisi, they'll announce after the close today that they've regained NASDAQ compliance. It'll come on a Friday afternoon when nobody is watching. on a day when the market suffered a meltdown. Typical Lisi

0 · Reply

midnite_clyde Aug. 1 at 5:01 PM

$XAIR Thought I was smart yesterday to buy a bundle @$3.00/share. Oh well.

2 · Reply

MavisBeacon Aug. 1 at 2:15 PM

$XAIR .1395 pre r/s

0 · Reply

Say_Whaaaat Aug. 1 at 1:33 PM

$XAIR LMAO, never fails. Add and it dips

1 · Reply

JohnnyAceParisi Aug. 1 at 8:50 AM

$XAIR when I check this for the first time in months at 4:30 am

0 · Reply

Spiritualagent Aug. 1 at 6:40 AM

$XAIR https://www.linkedin.com/posts/beyondair_introducing-lungfitph-and-the-power-to-transform-activity-7356777227801292800-bFqn?utm_source=li_share&utm_content=feedcontent&utm_medium=g_mb_web&utm_campaign=copy

0 · Reply

MavisBeacon Aug. 1 at 2:39 AM

$XAIR .146 pre r/s. It just will not stop falling. I don't think I've ever seen anything like it. All stocks, regardless how trash they are, have good periods. But not this one. It's just straight down. Pops last a few hours af most and then immediately fade

1 · Reply

VernCapital Jul. 31 at 9:09 PM

$XAIR 50ma around 3.57 ….better hope this 2.90 holds because the more we keep testing this support area the greater chance is fails and turns to resistance. basically what we’ve experienced for 2 years with constant levels failing. what changes 🤷🏻‍♂️ earnings ? and will that be much different to what they guided on the last call

3 · Reply

sodabox Jul. 31 at 8:49 PM

$XAIR To be honest, I was a big believer in this stock. I love the product… but not the management. I had 77k stocks and sold with a 15k loss, in three weeks in new investment it’s only 7.5k loss now. Mind wise it was the best decision for me. I keep checking this stock, but I don’t feel sorry anymore.

0 · Reply

Say_Whaaaat Jul. 31 at 3:45 PM

$XAIR I haven't added here in a long time. This morning I had to grab a few more for this earnings call.

1 · Reply

MavisBeacon Jul. 31 at 2:26 PM

$XAIR Surely this is the bottom. Surely...

0 · Reply

Market Cap	13.22M
Revenue (ttm)	3.71M
Net Income (ttm)	-46.63M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,256.87%
Debt to Equity Ratio	0.68

Volume	79,800
Avg Vol	279,401
Day's Range	N/A - N/A
Shares Out	4.64M
Stochastic %K	1%
Beta	0.25
Analysts	Strong Sell
Price Target	$11.50